These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8737523)

  • 21. Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment.
    Tyring SK
    Am J Obstet Gynecol; 2003 Sep; 189(3 Suppl):S17-23. PubMed ID: 14532899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node findings and outcome in squamous cell carcinoma of the vulva.
    Homesley HD
    Cancer; 1994 Nov; 74(9):2399-402. PubMed ID: 7922992
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of TP53 mutations in vulvar carcinomas.
    Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R
    Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic factors in invasive squamous epithelial cancer of the vulva].
    Petru E; Lahousen M; Pickel H; Heydarfadai M; Haas J; Kleewein P; Eibel K
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():26-7. PubMed ID: 1286337
    [No Abstract]   [Full Text] [Related]  

  • 25. microRNA portraits in human vulvar carcinoma.
    de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer.
    Vanin K; Scurry J; Thorne H; Yuen K; Ramsay RG
    J Invest Dermatol; 2002 Nov; 119(5):1027-33. PubMed ID: 12445188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in invasive squamous cell carcinoma of the vulva.
    Frankman O; Kabulski Z; Nilsson B; Silfverswärd C
    Int J Gynaecol Obstet; 1991 Nov; 36(3):219-28. PubMed ID: 1685457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in squamous cell cancer of the vulva and the implications for treatment.
    van der Velden J; Hacker NF
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):3-7. PubMed ID: 8777255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal histology and nomenclature of the vulva, and malignant neoplasms, including VIN.
    Wilkinson EJ
    Dermatol Clin; 1992 Apr; 10(2):283-96. PubMed ID: 1606760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
    Emanuels AG; Koudstaal J; Burger MP; Hollema H
    Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Individualized surgical therapy of vulvar carcinoma].
    Schwarz R
    Zentralbl Gynakol; 1996; 118(6):350-3. PubMed ID: 8768012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistologic detection of nm23-H1 protein in squamous cell carcinoma of the vulva.
    Hantschmann P; Beysiegel S; Assemi C; Kurzl R
    J Reprod Med; 2004 Oct; 49(10):787-95. PubMed ID: 15568401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ROCK1 as a novel prognostic marker in vulvar cancer.
    Akagi EM; Lavorato-Rocha AM; Maia Bde M; Rodrigues IS; Carvalho KC; Stiepcich MM; Baiocchi G; Sato-Kuwabara Y; Rogatto SR; Soares FA; Rocha RM
    BMC Cancer; 2014 Nov; 14():822. PubMed ID: 25380619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical staging of invasive squamous cell carcinoma of the vulva. Analysis of treatment and survival.
    Origoni M; Dindelli M; Ferrari D; Frigerio L; Rossi M; Ferrari A
    Int Surg; 1996; 81(1):67-70. PubMed ID: 8803710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.
    Rouzier R; Morice P; Haie-Meder C; Lhomme C; Avril MF; Duvillard P; Castaigne D
    Gynecol Oncol; 2001 Jun; 81(3):414-9. PubMed ID: 11371131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis.
    Wang Z; Slipicevic A; Førsund M; Trope CG; Nesland JM; Holm R
    PLoS One; 2015; 10(4):e0121398. PubMed ID: 25849598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.
    Lavorato-Rocha AM; de Melo Maia B; Rodrigues IS; Stiepcich MM; Baiocchi G; da Silva Cestari FM; Carvalho KC; Soares FA; Rocha RM
    Ann Surg Oncol; 2013 Jan; 20(1):31-9. PubMed ID: 22878614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is involvement of the clitoris in epidermoid carcinoma of the vulva an adverse prognostic sign?].
    Masák L; Hudáková G
    Ceska Gynekol; 1996 Oct; 61(5):299-301. PubMed ID: 9004977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
    Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
    J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.